This analysis reveals multidrug-resistant Pseudomonas aeruginosa strains in China, indicating a growing issue for antimicrobial treatment.
In summary, we report a clinical P. aeruginosa isolate from China co-harbouring blaKPC-2 and blaNDM-9. The emergence of multi-carbapenemase-producing strains poses a serious threat to antimicrobial therapy, underscoring the need for continuous clinical surveillance.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: